Clinical Trials Browser

Recruiting × Recurrence × Clinical Trials, Phase II as Topic × Clear all

NCT05958121 2025-11-18

IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors

Phase 1/2 Recruiting

Neoplasms, Recurrence